The Potential Economic Value of Lecanemab in Patients with Early Alzheimer ’s Disease Using Simulation Modeling

ConclusionThe early model predicted that lecanemab would potentially improve long-term health outcomes and reduce formal and informal care costs, resulting in a range of VBPs that reflect the value of lecanemab to society.
Source: Neurology and Therapy - Category: Neurology Source Type: research